# | Drug | Count |
---|---|---|
0 | ASPIRIN | 18 |
1 | ASPIRIN 325 MG | 18 |
2 | ASPIRIN 81 MG | 18 |
3 | ASPIRIN TABLET 325MG | 18 |
4 | SIMVASTATIN | 14 |
5 | ATORVASTATIN CALCIUM | 13 |
6 | HYDROCHLOROTHIAZIDE | 13 |
7 | LISINOPRIL | 13 |
8 | VALSARTAN | 12 |
9 | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, SODIUM PHOSPHATE, DIBASIC ANHYDROUS | 11 |
# | Drug | Count | Frequency |
---|---|---|---|
0 | SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC | 8 | 0.1290 |
1 | ENEMA | 8 | 0.0800 |
2 | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, SODIUM PHOSPHATE, DIBASIC ANHYDROUS | 11 | 0.0410 |
3 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | 4 | 0.0047 |
4 | BISACODYL | 10 | 0.0009 |
5 | MAGNESIUM HYDROXIDE | 7 | 0.0006 |
6 | NABUMETONE | 2 | 0.0003 |
7 | GLUCAGON | 1 | 0.0003 |
8 | BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY | 1 | 0.0003 |
9 | MARC GLASSMAN | 1 | 0.0003 |
# | Drug class | Count |
---|---|---|
0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 35 |
1 | Angiotensin 2 Receptor Blocker [EPC] | 23 |
2 | Platelet Aggregation Inhibitor [EPC] | 20 |
3 | HMG-CoA Reductase Inhibitor [EPC] | 17 |
4 | Thiazide Diuretic [EPC] | 17 |
5 | Stimulant Laxative [EPC] | 10 |
6 | Benzodiazepine [EPC] | 9 |
7 | Calcium [EPC] | 9 |
8 | Non-Standardized Chemical Allergen [EPC] | 8 |
9 | Osmotic Laxative [EPC] | 7 |
# | Drug class | Count | Frequency |
---|---|---|---|
0 | Stimulant Laxative [EPC] | 10 | 0.0009 |
1 | Non-Standardized Chemical Allergen [EPC] | 8 | 0.0004 |
2 | Antihypoglycemic Agent [EPC] | 1 | 0.0003 |
3 | Interleukin-2 Receptor Blocking Antibody [EPC] | 2 | 0.0002 |
4 | Antimetabolite Immunosuppressant [EPC] | 2 | 0.0002 |
5 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
6 | Alkaloid [EPC] | 3 | 0.0001 |
7 | Thiazide Diuretic [EPC] | 17 | 0.0001 |
8 | Thiazide-like Diuretic [EPC] | 3 | 0.0001 |
9 | Angiotensin 2 Receptor Blocker [EPC] | 23 | 0.0001 |